These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2022267)

  • 1. Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle.
    Espinosa de los Monteros A; Cornejo J; Parra A
    Fertil Steril; 1991 May; 55(5):885-9. PubMed ID: 2022267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related changes in the metoclopramide-induced prolactin release in nulliparous women.
    Parra A; Alarcón J; Gaviño F; Ramírez A; Espinosa de los Monteros A
    Fertil Steril; 1993 Jul; 60(1):34-9. PubMed ID: 8513956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the metoclopramide-induced prolactin release related to age at first full-term pregnancy or nulliparity.
    Parra A; Barrón J; Sinibaldi J; Coria I; Espinosa de los Monteros A
    Hum Reprod; 1997 Feb; 12(2):214-9. PubMed ID: 9070698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum prolactin during oral metoclopramide in normal nulliparous women].
    Ramírez A; Espinosa de los Monteros A; Coria I; Hortencia Valencia Q; Parra A
    Ginecol Obstet Mex; 1993 Apr; 61():96-101. PubMed ID: 8406122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hypothalamic dopaminergic tone only in early parous women with either malignant or benign breast tumors.
    Ortega-González C; Parra A; Barra R; Aranda C; Ramírez D; Di Castro P; Castro I; Zambrana M; Coria I
    Endocr Pract; 2002; 8(2):89-95. PubMed ID: 11942771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parity on pituitary prolactin response to metoclopramide and domperidone: implications for the enhancement of lactation.
    Brown TE; Fernandes PA; Grant LJ; Hutsul JA; McCoshen JA
    J Soc Gynecol Investig; 2000; 7(1):65-9. PubMed ID: 10732318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal and metoclopramide-stimulated prolactin (PRL) serum levels in users and non-users of a copper intrauterine device (TCu-380 IUD).
    Parra A; Gabiño F; Ramírez A; Valencia H; Coria I; Espinosa de los Monteros A
    Contraception; 1991 Nov; 44(5):541-7. PubMed ID: 1797468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin secretion during pregnancy and puerperium: response to metoclopramide and interactions with placental hormones.
    Bohnet HG; Kato K
    Obstet Gynecol; 1985 Jun; 65(6):789-92. PubMed ID: 3839061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women.
    Vescovi PP; Coiro V
    Drug Alcohol Depend; 1997 Apr; 45(1-2):115-9. PubMed ID: 9179513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ghrelin and metoclopramide on prolactin secretion in normal women.
    Messini CI; Dafopoulos K; Chalvatzas N; Georgoulias P; Anifandis G; Messinis IE
    J Endocrinol Invest; 2011 Apr; 34(4):276-9. PubMed ID: 20530986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.
    Yamaguchi M; Aono T; Koike K; Nishikawa Y; Ikegami H; Miyake A; Tanizawa O
    Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):187-91. PubMed ID: 2032589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved prolactin fluctuations and response to metoclopramide in ovulatory, infertile, hyperprolactinemic women.
    Andersen AN; Pedersen H; Larsen JF; Djursing H
    Acta Obstet Gynecol Scand; 1984; 63(2):141-4. PubMed ID: 6730927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.
    Agner T; Hagen C; Andersen AN; Djursing H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):778-82. PubMed ID: 3949956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic modulation of aldosterone secretion in the normal menstrual cycle.
    Garcia-Robles R; Ruilope LM; Tovar J; de Pablos P; Parada J; Hurtado A; Miranda B; Fernandez Vazquez G; Rodicio JL; Sancho J
    J Clin Hypertens; 1987 Dec; 3(4):470-8. PubMed ID: 3134515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased dopaminergic tone and increased basal bioactive prolactin in men with human immunodeficiency virus infection.
    Parra A; Ramírez-Peredo J; Larrea F; Cabrera V; Coutiño B; Torres I; Angeles A; Pérez-Romano B; Ruiz-Argüelles G; Ruiz-Argüelles A
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):731-8. PubMed ID: 11422107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast.
    Watt-Boolsen S; Eskildsen PC; Blaehr H
    Cancer; 1985 Aug; 56(3):500-2. PubMed ID: 4005811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of serum prolactin throughout the menstrual cycle and pregnancy in hyperprolactinemic women with normal ovarian function.
    Larrea F; Escorza A; Valero A; Hernandez L; Cravioto MC; Diaz-Sanchez V
    J Clin Endocrinol Metab; 1989 May; 68(5):982-7. PubMed ID: 2715295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women.
    Bernstein L; Pike MC; Ross RK; Judd HL; Brown JB; Henderson BE
    J Natl Cancer Inst; 1985 Apr; 74(4):741-5. PubMed ID: 3857369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different responses in little and bigbig prolactin to metoclopramide in subjects with hyperprolactinemia due to 150-170 kD (bigbig) prolactin.
    Bjøro T; Johansen E; Frey HH; Turter A; Torjesen PA
    Acta Endocrinol (Copenh); 1993 Apr; 128(4):308-12. PubMed ID: 8498149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.